Glucotrack, Inc. (GCTK) Form 8-K — Oct 22, 2026
$GCTKForm 8-KItems 1.01, 2.03, 3.02, 7.01, 9.01Filed Oct 22, 2026, 5:29 PM ET0001493152-26-048139Original filing
Glucotrack closed a $2.0M private placement via senior secured convertible notes ($2.56M principal, 22% OID, 8% interest, 9-month maturity). Notes convert at the lower of $0.6390 or 80% of lowest 15-day VWAP and are secured by substantially all assets. Investors received 200% warrant coverage (8,025,360 warrants at $1.5975), plus MFN rights, mandatory 50% repayment from ELOC proceeds, and penalty shares for registration/proxy delays. Issuances are capped at 19.99% pending stockholder approval.
Key figures
- Interest Rate
- 8
- Maturity Date
- Nine months from October 22, 2026
- Gross Proceeds
- 2000000
- Offering Price
- 0.639
- Exchange cap
- 19.99% absent stockholder approval
- Warrant shares
- 8025360
- Conversion terms
- lower of $0.6390 or 80% of lowest 15-day VWAP, floor at 20% of Nasdaq Minimum Price
- Placement agent fee
- 7%
- Reverse split ratio
- 1:2 effective October 26, 2026
- Default interest rate
- 18%
- Warrant exercise price
- 1.5975
- Original issue discount
- 22%
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.